I wish there were more discussion of the new type of Enhanze formulation which does not require refrigeration. The subject was kind of blown off with “the therapeutic molecule needs refrigeration anyway”. It well might, but some R&D into the field which pays the bills sounded interesting. Other than the cursed high volume auto injector, there is much silence about Halozyme R&D. Silence about the licensees, too, because of agreements.